Immune-excluded tumors were featured with an immune-suppressed TME, represented by T cells clearly embedded in the tumor stromal microenvironment with the presence of low MHC-I expression, TGF-β activation, myeloid inflammation, and angiogenesis (Hegde et al., 2016). This evidence concerns the gene TGFB1 and neoplasm.